CoChat

The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.

Screening and comorbidity of clinical levels of fear of cancer recurrence

Simard, Sébastien, Savard, Josée · 2015 · Journal of Cancer Survivorship

Abstract

Purpose The prevalence of clinical levels of fear of cancer recurrence (FCR) in cancer survivors is unknown, which may be partly explained by the lack of an assessment method that would make it possible to distinguish between normal and clinical levels of FCR. Moreover, despite the apparent overlap between FCR and manifestations of some psychiatric disorders, no study has yet evaluated the comorbidity of clinical levels of FCR. The goals of this study were to assess the capacity of the Fear of Cancer Recurrence Inventory severity subscale, to consider a shorter form of the FCRI (FCRI-SF), to screen for clinical levels of FCR, and to assess its psychiatric comorbidity.Methods Sixty French-Canadian cancer survivors (73% of those eligible) who had been treated within the past 4 years for localized breast, prostate, lung, or colorectal cancer were randomly selected. Participants were administered a clinical interview assessing FCR, the Structured Clinical Interview for DSM-IV, and self-report scales.Results A cutoff score of 13 or higher on the FCRI-SF was associated with optimal sensitivity (88%) and specificity (75%) rates for the screening of clinical levels of FCR. Cancer survivors with clinical levels of FCR were significantly more likely to meet the criteria for a current psychiatric disorder (60%) than patients with nonclinical levels (29%). Anxiety disorders tended to be the most common comorbid disorders.Conclusions/implications for cancer survivors The FCRI-SF allows rapid and effective screening of clinical levels of FCR, a condition associated with significant psychiatric comorbidity.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11764-015-0424-4

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

12 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 45 references

Research works printed but not linked: 1

  1. Fombonne E, Fuhrer R. L’application de l’analyse ROC en psychiatrie. Encéphale. 1995;18:545–50.

Cited by

See all 329

Metadata

Authors
Simard, S., & Savard, J.
Affiliations
  • Institut universitaire de cardiologie et de pneumologie de Québec (CA)
  • Université Laval (CA)
Corresponding author
Simard, Sébastien
Venue
Journal of Cancer Survivorship
Published
2015-01-21
Volume
9
Issue
3
Pages
481-491
ISSN
  • 1932-2259 (ISSN-L)
  • 1932-2267
OpenAlex
W1991276220
Cited by
329
References
46
Citations by year
2026: 24 · 2025: 45 · 2024: 41 · 2023: 38 · 2022: 43 · 2021: 31 · 2020: 18 · 2019: 33 · 2018: 17 · 2017: 18 · 2016: 14 · 2015: 6
FWCI
8.01
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Journal of Cancer Survivorship (publishedVersion)
  • PubMed (publishedVersion)
  • Constellation (Université du Québec à Chicoutimi) (acceptedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
fear of cancer recurrence, cancer survivors, screening cut-off values, psychiatric comorbidity, anxiety disorders, breast cancer, prostate cancer, lung cancer, colorectal cancer, psychological distress
MeSH terms
Fear, Female, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Neoplasms, Comorbidity, Survivors, Disease Progression, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Screening and comorbidity of clinical levels of fear of cancer recurrence. https://app.cochat.ai/papers/10.1007/s11764-015-0424-4
The paper
Simard, S., & Savard, J. (2015). Screening and comorbidity of clinical levels of fear of cancer recurrence. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-015-0424-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.